Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro.

Bulhões Portapilla, G, Pereira, LM, Bronzon da Costa, CM, Voltarelli Providello, M, Sampaio Oliveira, PA, Goulart, A, Ferreira Anchieta, N, Wainwright, M, Leite Braga, GÚ and de Albuquerque, S (2019) Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro. BioMed Research International, 2019. ISSN 2314-6133

Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro.pdf - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview


Chagas disease is a tropical illness caused by the protozoan Trypanosoma cruzi. The disease affects populations of the Americas and has been spread to other continents due to the migration process. The disease is partially controlled by two drugs, Benznidazole and Nifurtimox. These molecules are active in the acute phase of the infection but are usually ineffective during the symptomatic chronic phase. Several research groups have developed novel candidates to control Chagas disease; however, no novel commercial formulation is available. In this article, we described the anti-T. cruzi effects of phenothiazinium dyes in amastigote and trypomastigote forms of the parasite. Methylene Blue, New Methylene Blue, Toluidine Blue O, and 1,9-Dimethyl Methylene Blue inhibited the parasite proliferation at nanomolar concentrations and also demonstrated low toxicity in host cells. Moreover, combinations of phenothiazinium dyes indicated a synergic pattern against amastigotes compared to the Benznidazole counterparts. Phenothiazinium dyes levels of reactive oxygen species (ROS) and decreased the mitochondrial potential in trypomastigotes, indicating the mechanism of action of the dyes in T. cruzi. Our article offers a basis for future strategies for the control of Chagas disease using low-cost formulations, an important point for endemic underdeveloped regions.

Item Type: Article
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Hindawi Limited
Related URLs:
Date Deposited: 07 Aug 2019 09:10
Last Modified: 04 Sep 2021 09:02
DOI or ID number: 10.1155/2019/8301569
URI: https://researchonline.ljmu.ac.uk/id/eprint/11159
View Item View Item